OverviewSuggest Edit

Covetrus is an animal-health technology and services company. It provides technology solutions and related services including practice management software, data applications, and communication tools. The company also deliver prescription and appointment management services that help veterinarians with insights, client engagement tools, and integrated pharmacy services.
TypePublic
Founded2018
Websitecovetrus.com
Employee Ratings3.3
Overall CultureB

Latest Updates

Employees (est.) (Dec 2019)5,100
Job Openings542
Share Price (Jul 2021)$25.1(+5%)
Cybersecurity ratingCMore

Key People/Management at Covetrus

Benjamin Wolin

Benjamin Wolin

President and Chief Executive Officer, Director
Philip A. Laskawy

Philip A. Laskawy

Chairman of the Board
Deborah G. Ellinger

Deborah G. Ellinger

Director
Mike Ellis

Mike Ellis

Executive Vice President and President, Europe
Sandra L. Helton

Sandra L. Helton

Director
Paul R. Fonteyne

Paul R. Fonteyne

Director
Show more

Covetrus Financials and Metrics

Covetrus Revenue

Market capitalization (20-Jul-2021)

3.4b

Closing stock price (20-Jul-2021)

25.1
Covetrus's current market capitalization is $3.4 b.
Show all financial metrics

Covetrus Cybersecurity Score

Cybersecurity ratingPremium dataset

C

72/100

SecurityScorecard logo

Covetrus Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Covetrus Online and Social Media Presence

Embed Graph

Covetrus Company Culture

  • Overall Culture

    B

    72/100

  • CEO Rating

    A+

    85/100

  • Compensation

    D+

    58/100

  • Diversity

    B

    73/100

Learn more on Comparably

Covetrus News and Updates

COVETRUS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Covetrus, Inc. - CVET

NEW ORLEANS, March 5, 2021 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Covetrus, Inc. (NasdaqGS: CVET). On August 13, 2019, the Company...

Covetrus Announces Third Quarter 2020 Earnings Release Date and Conference Call Information

PORTLAND, Maine, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release third quarter 2020 results after the market close on Tuesday, November 10, 2020. Following the release, the company will hold a…

Covetrus Announces Second Quarter 2020 Earnings Release Date and Conference Call Information

PORTLAND, Maine, July 28, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release second quarter 2020 results after the market close on Tuesday, August 11, 2020. Following the release, the company will hold a …

Covetrus Declares Dividend on Perpetual Convertible Preferred Stock

PORTLAND, Maine, June 25, 2020 (GLOBE NEWSWIRE) -- Covetrus™ (NASDAQ: CVET), a global leader in animal-health technology and services, announced today its board of directors has declared a quarterly cash dividend to holders of its 7.50% Series A Convertible Preferred Stock of $8.653846 per share p…

Covetrus Frequently Asked Questions

  • When was Covetrus founded?

    Covetrus was founded in 2018.

  • Who are Covetrus key executives?

    Covetrus's key executives are Benjamin Wolin, Philip A. Laskawy and Deborah G. Ellinger.

  • How many employees does Covetrus have?

    Covetrus has 5,100 employees.

  • Who are Covetrus competitors?

    Competitors of Covetrus include Modern Animal, vetevo and Vetolib.